Outlook Therapeutics
OTLK
OTLK
76 hedge funds and large institutions have $29.3M invested in Outlook Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.02% less ownership
Funds ownership: 0.55% → 0.53% (-0.02%)
Holders
76
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$197K | |
| 2 | +$105K | |
| 3 | +$72.9K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$44K |
| 5 |
Squarepoint
New York
|
+$39K |
Top Sellers
| 1 | -$760K | |
| 2 | -$195K | |
| 3 | -$192K | |
| 4 |
Two Sigma Advisers
New York
|
-$188K |
| 5 |
BlackRock
New York
|
-$121K |